ArticleJournal of endocrinological investigation2013

Spironolactone prevents dietary-induced metabolic syndrome by inhibiting PI3-K/Akt and p38MAPK signaling pathways.

H D Long et al.PubMed ↗Publisher ↗

No numbers read from the abstract.